Global Pharma Industry: In Need of a New Business Model?


Code :BSM0023

Year :

Industry : Health Care

Region : Global

Teaching Note:Not Available

Structured Assignment :Not Available

Buy This Case Study

Abstract: Once celebrated as the engine of modern medical innovation, pharmaceutical firms are lambasted for the low productivity of their research, their wasteful marketing and, above all, for the high prices that their products command. The drug companies defend their prices, and their profits, by citing the high cost of making new drugs, more than US$800 million. This infuriates critics, who argue that the firms could easily lower prices and find savings on promotions without touching their precious research and development budgets. To meet this end they propose a new business model for the pharma giants, which will focus on lowering marketing budgets and embracing innovative methods in dealing with high costs of drug making.

For Case Books Click Here >>

For Case eBooks Click Here >>

Pedagogical Objectives:

  • To discuss the pros and cons of the existing business model
  • To discuss the essence of the proposed business model

    Keywords : Global Pharmaceutical Industry; Business model of drug companies; Drug industry; Big Pharma; Innovation in pharmaceuticals; Industry Analysis Case Study; Drug marketing; Advertising for drugs; Blockbuster drugs; Patent laws for drugs; Cost components of drug companies; Research and development in drug companies

    Contents :
    The Hollows behind the Halos
    Developing the Right Business Composition

    Case Introduction >>

  • Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
    Mob: +91- 9640901313,

    2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap